The Gut–Heart Axis: A Comprehensive Review of Microbiota’s Role in Cardiovascular Health and Disease and Emerging Therapeutic Strategies
Cardiology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/crp/9920016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology Research and Practice, online erschienen am 09.02.2026. Verfasst von Maneeth Mylavarapu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Endeavor Health Cardiovascular Institute, Glenview, Illinois, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This review examines the bidirectional relationship between the gut microbiota and cardiovascular diseases (CVDs), aiming to understand how microbial dysbiosis contributes to CVDs, including atherosclerosis, hypertension, and heart failure. Recent research emphasizes the gut microbiota’s role in modulating immunity via SCFAs and tryptophan metabolites, maintaining intestinal barrier integrity, and producing metabolites such as SCFAs (acetate, propionate, butyrate) and pro‐atherogenic TMAO. Dietary patterns, particularly the Mediterranean versus Western diet, significantly influence gut microbiota composition and CVD risk. Polyphenols and exercise have shown positive effects on gut microbiota and cardiovascular outcomes. A significant interplay exists between gut microbiota and cardiovascular health. Dysbiosis and metabolites like TMAO and LPS are implicated in CVD, while SCFAs and a balanced microbiota offer protection. Future research should focus on precision medicine, next‐gen probiotics, optimized FMT, and multiomics approaches to identify personalized CVD therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Endeavor Health Cardiovascular Institute, Glenview, Illinois, USA.
- Division of Cardiology, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illnois, USA, uchicago.edu.
- Department of Internal Medicine, Maharani Laxmi Bai Medical College, Jhansi, Uttar Pradesh, India.
- Department of Internal Medicine, Honor Health Mountain Vista, Midwestern University, Mesa, Arizona, USA, midwestern.edu.
- Department of Internal Medicine, Trinity Health Oakland Hospital, Pontiac, Michigan, USA.
- Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan, duhs.edu.pk.
ORCID-Profile: Maneeth Mylavarapu, Angad Tiwari, Roopeessh Vempati, Harendra Kumar, Lakshmi Sai Meghana Kodali, Sriharsha Dadana, Israel Garcia, Fabio Enrique Parada Cabrera
Zitieren
APA
Mylavarapu, M., Tiwari, A., Kaur, H., Vempati, R., Kumar, H., Kodali, L. S. M., Khan, K. G., Dadana, S., Garcia, I., Cabrera, F. E. P., Singh, A., Kyasa, S. L., & Purewal, V. S. (2026). The Gut–Heart Axis: A Comprehensive Review of Microbiota’s Role in Cardiovascular Health and Disease and Emerging Therapeutic Strategies. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/9920016
Vancouver
Mylavarapu M, Tiwari A, Kaur H, Vempati R, Kumar H, Kodali LSM, et al. The Gut–Heart Axis: A Comprehensive Review of Microbiota’s Role in Cardiovascular Health and Disease and Emerging Therapeutic Strategies. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/9920016
BibTeX
@article{Mylavarapu2026,
author = {Mylavarapu, Maneeth and Tiwari, Angad and Kaur, Harshaman and Vempati, Roopeessh and Kumar, Harendra and Kodali, Lakshmi Sai Meghana and Khan, Kiyan Ghani and Dadana, Sriharsha and Garcia, Israel and Cabrera, Fabio Enrique Parada and Singh, Amninder and Kyasa, Sai Lakhan and Purewal, Vikramjit S},
title = {The Gut–Heart Axis: A Comprehensive Review of Microbiota’s Role in Cardiovascular Health and Disease and Emerging Therapeutic Strategies},
journal = {Cardiology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crp/9920016}
}
EUVIMED